In this article, we are going to delve into AM-919, a topic that has sparked interest and debate in recent times. AM-919 is a topic that has captured the attention of experts, enthusiasts and the general public, due to its relevance in various fields. From its impact on society to its influence on popular culture, AM-919 has proven to be a topic of great importance today. Throughout this article, we will explore different aspects of AM-919, analyzing its origin, evolution and impact on society. Additionally, we will examine possible future scenarios and consider their importance in today's world.
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C27H44O4 |
Molar mass | 432.645 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
AM-919 (part of the AM cannabinoid series) is an analgesic drug which is a cannabinoid receptor agonist. It is a derivative of HU-210 which has been substituted with a 6β-(3-hydroxypropyl) group. This adds a "southern" aliphatic hydroxyl group to the molecule as seen in the CP-series of nonclassical cannabinoid drugs, and so AM-919 represents a hybrid structure between the classical dibenzopyran and nonclassical cannabinoid families.[1]
AM-919 is somewhat less potent than HU-210 itself, but is still a potent agonist at both CB1 and CB2 with moderate selectivity for CB1, with a Ki of 2.2 nM at CB1 and 3.4 nM at CB2.[2][3]